Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-14

Clinical Trial Update: Abaloparatide and Pelvic Fracture Healing [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating abaloparatide for pelvic fracture healing has completed. The update summarizes the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abaloparatide (abaloparatide)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Fracture of Pelvis (Disorder) | Phase 2 | Status: COMPLETED